Association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and Graves' disease risk: A meta-analysis of 11 case-control studies

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Chen, Min Li ^a   Liao, Ning ^a   Zhao, Hua ^a   Huang, Jian ^a   Xie, Zheng Fu ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA;

ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GRAVES DISEASE; HOMOZYGOSITY; HUMAN; IL1B GENE; IL1RN GENE; RISK ASSESSMENT; VARIABLE NUMBER OF TANDEM REPEAT;

CASE-CONTROL STUDIES; GENES, RECESSIVE; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HOMOZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MINISATELLITE REPEATS; MODELS, GENETIC; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK FACTORS;

EID: 84908164762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086077     Document Type: Article

References (39)

1. Weetman AP (2000) Graves' disease. N Engl J Med 343:1236-1248.
2. Prabhakar BS, Bahn RS, Smith TJ (2003) Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24:802-835. (Pubitemid 38067700)
3. Heufelder AE (2000) Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev Endocr Metab Disord 1:87-95.
4. Brinster NK, Garrett AB, Kostopoulos TC (2013) Localized myxedema of thyroid disease. J Am Acad Dermatol 68:e189-190.
5. Hemminki K, Li X, Sundquist J, Sundquist K (2010) The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 34:J307-313.
6. Tomer Y (2010) Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20:715-725.
7. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, et al. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89:5862-5865. (Pubitemid 39518482)
8. Ban Y, Tomer Y (2005) Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol 12:47-58. (Pubitemid 41647030)
9. Zhao SX, Pan CM, Cao HM, Han B, Shi JY,et al. (2010) Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PLoS One 5:e9821.
10. Jurecka-Lubieniecka B, Ploski R, Kula D, Krol A, Bednarczuk T, et al. (2013) Association between age at diagnosis of Graves' disease and variants in genes involved in immune response. PLoS One 8:e59349.
11. García-González MA, Aísa MA, Strunk M, Benito R, Piazuelo E, et al. (2009) R elevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal production. Hum Immunol 70:935-945.
12. Stegger JG, Schmidt EB, Tjønneland A, Kopp TI, Sørensen TI, et al. (2012) Single nucleotide polymorphisms in IL1B and the risk of acute coronary syndrome: a Danish case-cohort study. PLoS One 7:e36829.
13. Jaiswal D, Trivedi S, Singh R, Dada R, Singh K (2012) Association of the IL1RN gene VNTR polymorphism with human male infertility. PLoS One 7:e51899.
14. Blakemore AI, Watson PF, Weetman AP, Duff GW (1995) Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 80:111-115.
15. Cuddihy RM, Bahn RS (1996) Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. J Clin Endocrinol Metab 81:4476-4478. (Pubitemid 26412064)
16. Mühlberg T, Kirchberger M, Spitzweg C, Herrmann F, Heberling HJ, et al. (1998) Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur J Endocrinol 138:686-690. (Pubitemid 28313820)
17. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA, et al. (2000) Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 85:1984-1988. (Pubitemid 32269309)
18. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, et al. (2000) Complex association analysis of graves disease using a set of polymorphic markers. Mol Genet Metab 70:214-218. (Pubitemid 30642562)
19. Reichmann I, Schulte KM, Roeher HD (2004) No association of IL-1beta C+3954 T polymorphism and thyroid disease. Exp Clin Endocrinol Diabetes 112:440-443. (Pubitemid 39311026)
20. Chen RH, Chen WC, Chang CT, Tsai CH, Tsai FJ (2005) Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J Clin Lab Anal 19:133-138. (Pubitemid 41060218)
21. Nakkuntod J, Wongsurawat T, Charoenwongse P, Snabboon T, Sridama V, et al. (2006) Association of TNF-alpha, TNF-beta, IFN-gamma and IL-1Ra gene polymorphisms with Graves' disease in the Thai population. Asian Pac J Allergy Immunol 24:207-211. (Pubitemid 46332268)
22. Kammoun-Krichen M, Bougacha-Elleuch N, Makni K, Rebai M, Peraldi-Roux S, et al. (2007) Association analysis of interleukin gene polymorphisms in autoimmune thyroid diseases in the Tunisian population. Eur Cytokine Netw 18:196-200.
23. Lacka K, Paradowska A, Gasinska T, Soszynska J, Wichary H, et al. (2009) Interleukin-1beta gene (IL-1beta) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population. Curr Eye Res 34:215-220.
24. Khalilzadeh O, Anvari M, Esteghamati A, Mahmoudi M, Tahvildari M, et al. (2009) Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist. Clin Experiment Ophthalmol 37:614-619.
25. Liu N, Li X, Liu C, Zhao Y, Cui B, et al. (2010) The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case-control study and meta-analysis. Hum Immunol 71:397-401.
26. Khalilzadeh O, Anvari M, Esteghamati A, Momen-Heravi F, Mahmoudi M, et al. (2010) The interleukin-1 family gene polymorphisms and Graves' disease. Ann Endocrinol (Paris) 71:281-285.
27. Liu YH, Chen RH, Wu HH, Liao WL, Chen WC, et al. (2010) Association of interleukin-1beta (IL1B) polymorphisms with Graves' ophthalmopathy in Taiwan Chinese patients. Invest Ophthalmol Vis Sci 51:6238-6246
28. MANTEL N, HAENSZEL W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
30. Kavvoura FK, Ioannidis JP (2008) Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 123:1-14.
31. Ashizawa K, Yamashita S, Tobinaga T, Nagayama Y, Kimura H, et al. (1989) Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol (Copenh) 121:465-469. (Pubitemid 19244529)
32. Nilsson M, Husmark J, Björkman U, Ericson LE (1998) Cytokines and thyroid epithelial integrity: interleukin-1alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J Clin Endocrinol Metab 83:945-952. (Pubitemid 28496474)
33. Rasmussen AK, Feldt-Rasmussen U, Bendtzen K (1993) The effect of interleukin-1 on the thyroid gland. Autoimmunity 16:141-148. (Pubitemid 24060872)
34. Dinarello CA (1997) Interleukin-1. Cytokine Growth Factor Rev 8:253-265.
35. Yoon JS, Lee HJ, Choi SH, Chang EJ, Lee SY, et al. (2011) Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy. PLoS One 6:e26261.
36. Paik JS, Cho WK, Oh EH, Lee SB, Yang SW (2012) Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy. Mol Vis 18:1467-1477.
37. Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y (2001) IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol 167:90-97. (Pubitemid 32567765)
38. Nanba T, Watanabe M, Inoue N, Iwatani Y (2009) Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 19:495-501.
39. Al-Tahhan MA, Etewa RL, El Behery MM (2011) Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem 353:159-165.